Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Chemogenetic manipulation of parasympathetic neurons (DMV) regulates feeding behavior and energy metabolism.

NamKoong C, Song WJ, Kim CY, Chun DH, Shin S, Sohn JW, Choi HJ.

Neurosci Lett. 2019 Aug 27;712:134356. doi: 10.1016/j.neulet.2019.134356. [Epub ahead of print]

2.

Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively.

Zhan C, Zhou J, Feng Q, Zhang JE, Lin S, Bao J, Wu P, Luo M.

J Neurosci. 2013 Feb 20;33(8):3624-32. doi: 10.1523/JNEUROSCI.2742-12.2013.

3.

Cholinergic neurons in the dorsomedial hypothalamus regulate food intake.

Jeong JH, Lee DK, Jo YH.

Mol Metab. 2017 Jan 12;6(3):306-312. doi: 10.1016/j.molmet.2017.01.001. eCollection 2017 Mar.

4.

Testing Effects of Chronic Chemogenetic Neuronal Stimulation on Energy Balance by Indirect Calorimetry.

Yu S, Münzberg H.

Bio Protoc. 2018 Apr 20;8(8). pii: e2811. doi: 10.21769/BioProtoc.2811.

5.

Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.

Ji B, Kaneko H, Minamimoto T, Inoue H, Takeuchi H, Kumata K, Zhang MR, Aoki I, Seki C, Ono M, Tokunaga M, Tsukamoto S, Tanabe K, Shin RM, Minamihisamatsu T, Kito S, Richmond BJ, Suhara T, Higuchi M.

J Neurosci. 2016 Nov 9;36(45):11544-11558.

6.

The role of ghrelin-responsive mediobasal hypothalamic neurons in mediating feeding responses to fasting.

Mani BK, Osborne-Lawrence S, Mequinion M, Lawrence S, Gautron L, Andrews ZB, Zigman JM.

Mol Metab. 2017 Jun 22;6(8):882-896. doi: 10.1016/j.molmet.2017.06.011. eCollection 2017 Aug.

7.

Activation of SF1 Neurons in the Ventromedial Hypothalamus by DREADD Technology Increases Insulin Sensitivity in Peripheral Tissues.

Coutinho EA, Okamoto S, Ishikawa AW, Yokota S, Wada N, Hirabayashi T, Saito K, Sato T, Takagi K, Wang CC, Kobayashi K, Ogawa Y, Shioda S, Yoshimura Y, Minokoshi Y.

Diabetes. 2017 Sep;66(9):2372-2386. doi: 10.2337/db16-1344. Epub 2017 Jul 3.

8.

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.

Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M.

Science. 2017 Aug 4;357(6350):503-507. doi: 10.1126/science.aan2475.

PMID:
28774929
9.

Role of POMC and AgRP neuronal activities on glycaemia in mice.

Üner AG, Keçik O, Quaresma PGF, De Araujo TM, Lee H, Li W, Kim HJ, Chung M, Bjørbæk C, Kim YB.

Sci Rep. 2019 Sep 10;9(1):13068. doi: 10.1038/s41598-019-49295-7.

10.

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo.

Thompson KJ, Khajehali E, Bradley SJ, Navarrete JS, Huang XP, Slocum S, Jin J, Liu J, Xiong Y, Olsen RHJ, Diberto JF, Boyt KM, Pina MM, Pati D, Molloy C, Bundgaard C, Sexton PM, Kash TL, Krashes MJ, Christopoulos A, Roth BL, Tobin AB.

ACS Pharmacol Transl Sci. 2018 Sep 14;1(1):61-72. doi: 10.1021/acsptsci.8b00012. Epub 2018 Jul 27.

12.

The role of GluN2A and GluN2B NMDA receptor subunits in AgRP and POMC neurons on body weight and glucose homeostasis.

Üner A, Gonçalves GH, Li W, Porceban M, Caron N, Schönke M, Delpire E, Sakimura K, Bjørbæk C.

Mol Metab. 2015 Jul 6;4(10):678-91. doi: 10.1016/j.molmet.2015.06.010. eCollection 2015 Oct.

13.

Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.

MacLaren DA, Browne RW, Shaw JK, Krishnan Radhakrishnan S, Khare P, España RA, Clark SD.

eNeuro. 2016 Nov 1;3(5). pii: ENEURO.0219-16.2016. eCollection 2016 Sep-Oct.

14.

Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.

Upright NA, Brookshire SW, Schnebelen W, Damatac CG, Hof PR, Browning PGF, Croxson PL, Rudebeck PH, Baxter MG.

J Neurosci. 2018 Sep 12;38(37):7969-7975. doi: 10.1523/JNEUROSCI.1422-18.2018. Epub 2018 Aug 6.

15.

Neuromodulation of orexin neurons reduces diet-induced adiposity.

Zink AN, Bunney PE, Holm AA, Billington CJ, Kotz CM.

Int J Obes (Lond). 2018 Apr;42(4):737-745. doi: 10.1038/ijo.2017.276. Epub 2017 Nov 28.

16.

The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.

Chen X, Choo H, Huang XP, Yang X, Stone O, Roth BL, Jin J.

ACS Chem Neurosci. 2015 Mar 18;6(3):476-84. doi: 10.1021/cn500325v. Epub 2015 Jan 27.

17.

Rapid, reversible activation of AgRP neurons drives feeding behavior in mice.

Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS, Maratos-Flier E, Roth BL, Lowell BB.

J Clin Invest. 2011 Apr;121(4):1424-8. doi: 10.1172/JCI46229.

18.

Activation of orexin system facilitates anesthesia emergence and pain control.

Zhou W, Cheung K, Kyu S, Wang L, Guan Z, Kurien PA, Bickler PE, Jan LY.

Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10740-E10747. doi: 10.1073/pnas.1808622115. Epub 2018 Oct 22.

20.

Lipopolysacharide Rapidly and Completely Suppresses AgRP Neuron-Mediated Food Intake in Male Mice.

Liu Y, Huang Y, Liu T, Wu H, Cui H, Gautron L.

Endocrinology. 2016 Jun;157(6):2380-92. doi: 10.1210/en.2015-2081. Epub 2016 Apr 25.

Supplemental Content

Support Center